Prescott Group Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,500	Closed	-$1.2M	–	257
2024 Q4	$1.2M	Hold	6,500	–	–	0.16%	161
2024 Q3	$1.28M	Hold	6,500	–	–	0.19%	143
2024 Q2	$1.34M	Hold	6,500	–	–	0.21%	132
2024 Q1	$1.76M	Hold	6,500	–	–	0.28%	107
2023 Q4	$1.54M	Hold	6,500	–	–	0.27%	107
2023 Q3	$1.27M	Hold	6,500	–	–	0.28%	101
2023 Q2	$1.37M	Buy	6,500 +2,000	+44%	+$398K	0.3%	102
2023 Q1	$908K	Hold	4,500	–	–	0.21%	118
2022 Q4	$981K	Buy	+4,500	New	+$983K	0.21%	113
2022 Q1	–	Sell	-2,500	Closed	-$942K	–	151
2021 Q4	$942K	Sell	2,500 -118	-5%	-$45.8K	0.21%	121
2021 Q3	$1.08M	Buy	2,618 +50	+2%	+$20.8K	0.3%	103
2021 Q2	$950K	Buy	2,568 +68	+3%	+$22.7K	0.27%	89
2021 Q1	$725K	Buy	+2,500	New	+$695K	0.21%	98
2020 Q2	–	Sell	-3,029	Closed	-$382K	–	97
2020 Q1	$382K	Buy	+3,029	New	+$454K	0.19%	90
2015 Q3	–	Sell	-16,884	Closed	-$1.19M	–	169
2015 Q2	$1.19M	Hold	16,884	–	–	0.24%	114
2015 Q1	$1.34M	Buy	16,884 +6,083	+56%	+$449K	0.27%	105
2014 Q4	$687K	Buy	+10,801	New	+$677K	0.11%	157